Paulo César Ghedini Selected Research

Paulo César Ghedini Research Topics

Disease

4	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024 - 01/2018
2	Memory Disorders (Memory Loss) 02/2024 - 01/2022
2	Edema (Dropsy) 10/2023 - 01/2017
2	Pain (Aches) 10/2023 - 01/2017
2	Pleurisy (Pleuritis) 01/2023 - 01/2017
2	Cognitive Dysfunction 01/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2021 - 05/2020
2	Treatment-Resistant Schizophrenia 01/2020 - 12/2015
2	Ulcer 09/2014 - 01/2013
2	Stomach Ulcer (Gastric Ulcer) 09/2014 - 01/2013
1	Cardiomegaly (Heart Hypertrophy) 03/2024
1	Hyperalgesia 10/2023
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 05/2023
1	Hyperplasia 05/2023
1	Neuroinflammatory Diseases 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Hypertrophy 12/2021
1	Fibrosis (Cirrhosis) 12/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Anxiety Disorders (Anxiety Disorder) 05/2020
1	Major Depressive Disorder (Major Depressive Disorders) 05/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Necrosis 01/2018

Drug/Important Bio-Agent (IBA)

4	AntioxidantsIBA 04/2024 - 01/2018
3	Aluminum ChlorideIBA 02/2024 - 01/2022
3	Glutathione (Reduced Glutathione)IBA 10/2023 - 01/2021
2	CytokinesIBA 10/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2023
2	CarrageenanIBA 10/2023 - 01/2017
2	LQFM212IBA 01/2023 - 01/2021
2	AluminumIBA 01/2022 - 01/2018
2	Cytochrome P-450 CYP2C19IBA 05/2020 - 01/2020
2	Acetic Acid (Vinegar)FDA LinkGeneric 01/2017 - 09/2014
2	Ethanol (Ethyl Alcohol)IBA 09/2014 - 01/2013
2	HexanesIBA 09/2014 - 01/2013
1	Butylated Hydroxytoluene (BHT)IBA 04/2024
1	Piribedil (Trivastal)IBA 04/2024
1	angiotensin I (1-7)IBA 03/2024
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2023
1	Estrogen Receptor alphaIBA 05/2023
1	Androgen Receptors (Androgen Receptor)IBA 05/2023
1	CatalaseIBA 01/2023
1	Cholinesterases (Cholinesterase)IBA 01/2023
1	Malondialdehyde (Propanedial)IBA 01/2023
1	Peroxidase (Myeloperoxidase)IBA 01/2023
1	NitritesIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Superoxide DismutaseIBA 01/2023
1	chrysinIBA 01/2022
1	AcetylcholinesteraseIBA 01/2022
1	ButyrylcholinesteraseIBA 01/2022
1	MetalsIBA 01/2022
1	CollagenIBA 12/2021
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 12/2021
1	CreatinineIBA 01/2021
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021
1	PiperazineIBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021
1	Testosterone (Sustanon)FDA Link 05/2020
1	Escitalopram FDA Link 05/2020
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2020
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2020
1	EnzymesIBA 05/2020
1	Clozapine (Clozaril)FDA LinkGeneric 01/2020
1	Neuroprotective AgentsIBA 01/2018
1	1H-tetrazole (tetrazole)IBA 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 12/2015
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2013

Therapy/Procedure

1	Therapeutics 04/2024
1	Ligation 01/2013